Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma in Situ × Mastectomy, Subcutaneous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma in Situ 1 Breast Neoplasms 1

Interventions

valrubicin 1 dodecyl maltoside 1 Standard of Care 1 Physical Examination 1 Methods 1 Mastectomy, Subcutaneous 1 Erlotinib Hydrochloride 1 Educational Status 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02311959 2024-12-24

MAPAM-01

Institut Claudius Regaud

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡